science
investors
eXoZymes launches subsidiary, NCTx, to unlock a...
At the yearly SynBioBeta conference, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of...
investors
AI transforming biotechnology: From form with...
Co-founder and VP of Development at eXoZymes, Dr. Paul Opgenorth, states: "The Large Language...
science
BioClick - an enzyme engineering game-changer
BioClick: Exponentially increasing the rate of data acquisition by coupling AI with enzyme...
interview
How eXoZymes started: Interviews with Tyler...
Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how...
science
The difference between enzymes and exozymes:...
What is the difference between enzymes and exozymes? Listen to our CEO, Michael Heltzen, explain...
science
Vision: What's the potential impact of exozymes?
Listen to our CEO, Michael Heltzen (@heltzen), share his thoughts on how exozymes has the...
interview
The story of eXoZymes: Interview with Tyler...
Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how...